Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |